Christopher Dinsmore - 16 May 2024 Form 4/A Insider Report for Third Harmonic Bio, Inc. (THRD)

Role: Chief Scientific Officer
Signature: /c/ Christopher Murphy, Attorney-in-Fact
Issuer symbol: THRD
Transactions as of: 16 May 2024
Net transactions value: $0
Form type: 4/A
Filing time: 28 Jun 2024, 16:52:31 UTC
Date Of Original Report: 20 May 2024
Previous filing: 05 Jan 2024
Next filing: 17 Jan 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	THRD	Employee Stock Option (right to buy)	Award	$0	+297,000		$0.000000	297,000	16 May 2024	Common Stock	297,000	$14.23	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the total shares vest on May 16, 2025, and thereafter 2.08333% of the total shares underlying the award shall vest in equal monthly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.

Remarks:

The original Form 4, filed on May 20, 2024, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the number of options granted to the Reporting Person as 210,000 employee stock options.